The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
119437362 11943736 2 F 20150722 20160208 20160125 20160726 PER US-UNITED THERAPEUTICS-UNT-2015-010943 UNITED THERAPEUTICS 65.00 YR F Y 0.00000 20160726 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
119437362 11943736 1 PS ORENITRAM TREPROSTINIL 1 Oral 2.5 MG, TID 203496 2.5 MG TABLET TID
119437362 11943736 2 SS ORENITRAM TREPROSTINIL 1 Oral 1.5 MG, TID 203496 1.5 MG TABLET TID
119437362 11943736 3 SS ORENITRAM TREPROSTINIL 1 Oral 2.625 MG, TID 203496 2.625 MG TABLET TID
119437362 11943736 4 SS ORENITRAM TREPROSTINIL 1 Oral 0.375 MG, TID 203496 .375 MG TABLET TID
119437362 11943736 5 SS ORENITRAM TREPROSTINIL 1 Oral 3 MG, TID 203496 3 MG TABLET TID
119437362 11943736 6 SS AMBRISENTAN AMBRISENTAN 1 Unknown 10 MG, QD 1408789A 0 10 MG TABLET QD
119437362 11943736 7 SS AMBRISENTAN AMBRISENTAN 1 Unknown 10 MG, QD 1409095A 0 10 MG TABLET QD
119437362 11943736 8 SS ADCIRCA TADALAFIL 1 U U 0
119437362 11943736 9 C DEMADEX TORSEMIDE 1 0
119437362 11943736 10 C LEXAPRO ESCITALOPRAM OXALATE 1 0
119437362 11943736 11 C XANAX ALPRAZOLAM 1 0
119437362 11943736 12 C BONIVA IBANDRONATE SODIUM 1 0
119437362 11943736 13 C MULTIVITAMIN /07504101/ VITAMINS 1 0
119437362 11943736 14 C CHONDROITIN W/GLUCOSAMINE /02118501/ 2 0
119437362 11943736 15 C VITAMIN D CHOLECALCIFEROL 1 0
119437362 11943736 16 C FERROUS SULFATE. FERROUS SULFATE 1 0
119437362 11943736 17 C POTASSIUM CHLORIDE. POTASSIUM CHLORIDE 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
119437362 11943736 1 Pulmonary arterial hypertension
119437362 11943736 6 Pulmonary hypertension
119437362 11943736 8 Product used for unknown indication
119437362 11943736 9 Product used for unknown indication
119437362 11943736 10 Product used for unknown indication
119437362 11943736 11 Product used for unknown indication
119437362 11943736 12 Product used for unknown indication
119437362 11943736 13 Product used for unknown indication
119437362 11943736 14 Product used for unknown indication
119437362 11943736 15 Product used for unknown indication
119437362 11943736 16 Product used for unknown indication
119437362 11943736 17 Product used for unknown indication

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
119437362 11943736 Abdominal pain upper
119437362 11943736 Arthralgia
119437362 11943736 Diarrhoea
119437362 11943736 Nasal congestion
119437362 11943736 Pain in extremity
119437362 11943736 Weight decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
119437362 11943736 1 20150722 0
119437362 11943736 2 20150728 0
119437362 11943736 3 20150722 0
119437362 11943736 6 20120726 0